Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-23

Clinical Trial Update: A Study in Healthy Volunteers and Patients With Mild Asthma to Investigate the Safety, Anti-inflammatory Effect of Inhaled AZD0449 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and anti-inflammatory effects of inhaled AZD0449 in healthy volunteers and adults with mild asthma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZD0449

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 1 | Status: COMPLETED | Results posted: 2024-08-23